DISCARD Trial: Linear vs Hyperbolic Antidepressant Tapering Protocol
This protocol describes the first randomised head-to-head comparison of linear versus hyperbolic antidepressant tapering, addressing a longstanding evidence gap directly relevant to deprescribing practice.
Exploring safer ways to stop antidepressants in remitted depression.
Antidepressant overprescribing can lead to unnecessary long-term use and withdrawal symptoms, making safe discontinuation strategies essential. This trial compares linear versus hyperbolic tapering strategies for discontinuing antidepressants in adults with remitted depressive disorders over a 36-week period. The study addresses gaps in evidence by examining the effectiveness and safety of tapering strategies, crucial for optimizing patient outcomes during antidepressant discontinuation. This trial evaluates crucial strategies for safely tapering antidepressants, addressing adverse effects and withdrawal symptoms.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Ostuzzi G, Gastaldon C, Zaccoletti D, Bartoli F, Belnome G, Carrà G, Cavallotti S, Cristea I, D'Agostino A, De Fazio P, de Filippis R, Gottardi C, Novara C, Papola D, Riboldi I, Tedeschi F, Amaddeo F, Barbui C
Citation:Ostuzzi G, Gastaldon C, Zaccoletti D, et al. Safe discontinuation of antidepressants in individuals with clinically remitted depressive disorders: study protocol for a randomised controlled trial. BMJ open. 2026;16(7):e119492. doi:10.1136/bmjopen-2026-119492